Literature DB >> 15346918

Spinal muscle atrophy type 1 (Werdnig-Hoffman disease) with complex cardiac malformation.

Wael El-Matary1, Sunanda Kotagiri, Duncan Cameron, Ian Peart.   

Abstract

Entities:  

Mesh:

Year:  2004        PMID: 15346918     DOI: 10.1007/s00431-004-1437-6

Source DB:  PubMed          Journal:  Eur J Pediatr        ISSN: 0340-6199            Impact factor:   3.183


× No keyword cloud information.
  7 in total

1.  Spinal muscular atrophy combined with congenital heart disease: a report of two cases.

Authors:  W M Mulleners; C M van Ravenswaay; F J Gabreëls; B C Hamel; A van Oort; R C Sengers
Journal:  Neuropediatrics       Date:  1996-12       Impact factor: 1.947

2.  Syndrome of camptodactyly, multiple ankyloses, facial anomalies, and pulmonary hypoplasia: a lethal condition.

Authors:  S D Pena; M H Shokeir
Journal:  J Pediatr       Date:  1974-09       Impact factor: 4.406

3.  SMN gene deletion in variant of infantile spinal muscular atrophy.

Authors:  L Bürglen; R Spiegel; J Ignatius; J M Cobben; P Landrieu; S Lefebvre; A Munnich; J Melki
Journal:  Lancet       Date:  1995-07-29       Impact factor: 79.321

4.  Spinal muscular atrophy type I combined with atrial septal defect in three sibs.

Authors:  P Møller; N Moe; O D Saugstad; K Skullerud; M Velken; K Berg; S Nitter-Hauge; A L Børresen
Journal:  Clin Genet       Date:  1990-08       Impact factor: 4.438

5.  Cardiac involvement in Werdnig-Hoffmann's spinal muscular atrophy.

Authors:  J Finsterer; C Stöllberger
Journal:  Cardiology       Date:  1999       Impact factor: 1.869

6.  Clinical and molecular genetic features of congenital spinal muscular atrophy.

Authors:  K Devriendt; M Lammens; E Schollen; C Van Hole; R Dom; H Devlieger; J J Cassiman; J P Fryns; G Matthijs
Journal:  Ann Neurol       Date:  1996-11       Impact factor: 10.422

Review 7.  Spinal muscular atrophy: recent advances and future prospects.

Authors:  Sophie Nicole; Carmen Cifuentes Diaz; Tony Frugier; Judith Melki
Journal:  Muscle Nerve       Date:  2002-07       Impact factor: 3.217

  7 in total
  8 in total

1.  Arrhythmia and cardiac defects are a feature of spinal muscular atrophy model mice.

Authors:  Christopher R Heier; Rosalba Satta; Cathleen Lutz; Christine J DiDonato
Journal:  Hum Mol Genet       Date:  2010-08-06       Impact factor: 6.150

Review 2.  Spinal muscular atrophy: a motor neuron disorder or a multi-organ disease?

Authors:  Monir Shababi; Christian L Lorson; Sabine S Rudnik-Schöneborn
Journal:  J Anat       Date:  2013-07-22       Impact factor: 2.610

3.  SMN complex localizes to the sarcomeric Z-disc and is a proteolytic target of calpain.

Authors:  Michael P Walker; T K Rajendra; Luciano Saieva; Jennifer L Fuentes; Livio Pellizzoni; A Gregory Matera
Journal:  Hum Mol Genet       Date:  2008-08-08       Impact factor: 6.150

4.  Developmental and degenerative cardiac defects in the Taiwanese mouse model of severe spinal muscular atrophy.

Authors:  Gillian K Maxwell; Eva Szunyogova; Hannah K Shorrock; Thomas H Gillingwater; Simon H Parson
Journal:  J Anat       Date:  2018-02-22       Impact factor: 2.610

5.  Downregulation of Survivin contributes to cell-cycle arrest during postnatal cardiac development in a severe spinal muscular atrophy mouse model.

Authors:  Lei Sheng; Bo Wan; Pengchao Feng; Junjie Sun; Frank Rigo; C Frank Bennett; Martin Akerman; Adrian R Krainer; Yimin Hua
Journal:  Hum Mol Genet       Date:  2018-02-01       Impact factor: 6.150

6.  Antisense-based therapy for the treatment of spinal muscular atrophy.

Authors:  Frank Rigo; Yimin Hua; Adrian R Krainer; C Frank Bennett
Journal:  J Cell Biol       Date:  2012-10-01       Impact factor: 10.539

Review 7.  Cardiac pathology in spinal muscular atrophy: a systematic review.

Authors:  C A Wijngaarde; A C Blank; M Stam; R I Wadman; L H van den Berg; W L van der Pol
Journal:  Orphanet J Rare Dis       Date:  2017-04-11       Impact factor: 4.123

8.  Survival Motor Neuron (SMN) protein is required for normal mouse liver development.

Authors:  Eva Szunyogova; Haiyan Zhou; Gillian K Maxwell; Rachael A Powis; Francesco Muntoni; Thomas H Gillingwater; Simon H Parson
Journal:  Sci Rep       Date:  2016-10-04       Impact factor: 4.379

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.